Insights to ligand binding to the monoamine transporters – from homology modeling to LeuBAT and dDAT
Understanding of drug binding to the human biogenic amine transporters is essential to explain the mechanism of action of these pharmaceuticals but more importantly to be able to develop new and improved compounds to be used in the treatment of depression or drug addiction. Until recently no high re...
Main Authors: | Heidi eKoldsø, Julie eGrouleff, Birgit eSchiøtt |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00208/full |
Similar Items
-
Monoamine transporters: Insights from molecular dynamics simulations
by: Julie eGrouleff, et al.
Published: (2015-10-01) -
Effects of Hydroxylated Mephedrone Metabolites on Monoamine Transporter Activity in vitro
by: Marco Niello, et al.
Published: (2021-04-01) -
Designing Modulators of Monoamine Transporters using Virtual Screening Techniques
by: Ole Valente Mortensen, et al.
Published: (2015-09-01) -
Handling of intracellular K+ determines voltage dependence of plasmalemmal monoamine transporter function
by: Shreyas Bhat, et al.
Published: (2021-06-01) -
Amphetamine Derivatives as Monoamine Oxidase Inhibitors
by: Miguel Reyes-Parada, et al.
Published: (2020-01-01)